Ifabotuzumab (Synonyms: KB004) |
Katalog-Nr.GC69258 |
Ifabotuzumab (KB004) is an IgG1κ antibody targeting EphA3 (KD=610 pM). Ifabotuzumab can induce apoptosis of tumor cells and activate antibody-dependent cell-mediated cytotoxicity (ADCC), destroying the tumor vascular system. Ifabotuzumab can reduce CCR10+ cells in idiopathic pulmonary fibrosis (IPF) patients, improving lung fibrosis.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2147698-66-4
Sample solution is provided at 25 µL, 10mM.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *